THE EFFECTS OF OLMESARTAN/AMLODIPINE ON METABOLIC AND INFLAMMATION MEDIATORS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME ARE DOSE-DEPENDENT: THE OLAS STUDY

被引：0
|
作者：
Martinez Martin, F. [1 ]
机构：
[1] Hosp Dr Negrin, Endocrinol Dpt, Las Palmas Gran Canaria, Spain
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000378523.81991.01
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E107 / E108
页数：3
相关论文
共 50 条
  • [1] Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
    F J Martinez-Martin
    H Rodriguez-Rosas
    I Peiro-Martinez
    P Soriano-Perera
    P Pedrianes-Martin
    C Comi-Diaz
    Journal of Human Hypertension, 2011, 25 : 346 - 353
  • [2] Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
    Martinez-Martin, F. J.
    Rodriguez-Rosas, H.
    Peiro-Martinez, I.
    Soriano-Perera, P.
    Pedrianes-Martin, P.
    Comi-Diaz, C.
    JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (06) : 346 - 353
  • [3] Dose-Dependent Arterial Destiffening and Inward Remodeling After Olmesartan in Hypertensives With Metabolic Syndrome
    Laurent, Stephane
    Boutouyrie, Pierre
    HYPERTENSION, 2014, 64 (04) : 709 - +
  • [4] EFFECTS OF AMLODIPINE AND ATORVASTATIN ON ENDOTHELIAL VASOACTIVE MEDIATORS IN PATIENTS WITH METABOLIC SYNDROME
    Blinova, N.
    Masenko, V.
    Chazova, I.
    JOURNAL OF HYPERTENSION, 2016, 34 : E301 - E301
  • [5] DOSE-DEPENDENT EFFECTS OF ROSUVASTATIN ON THE PLASMA SPHINGOLIPIDOME IN THE METABOLIC SYNDROME
    Ng, T. W.
    Ooi, E. M.
    Watts, G. F.
    Chan, D. C.
    Meikle, P. J.
    Barrett, P. H. R.
    HYPERTENSION, 2014, 63 (06) : E170 - E170
  • [6] Inflammation in hypertensive patients with metabolic syndrome
    Avramakis, A. G.
    Koziri, A.
    Pitarokilis, M.
    Afendoulidou, K.
    De Philippis, L.
    Sfiraki, N.
    Papadakis, M.
    Papakonstanti, E.
    Koutsodimou, P.
    Dermitzakis, A.
    Glampedaki, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 494 - 494
  • [7] Effects of olmesartan on insulin resistance and inflammatory cytokines in hypertensive patients with metabolic syndrome
    Gonzalez Albarran, O.
    Lahera, M.
    Calvo, S.
    Paniagua, A.
    Aragon, C.
    Segura, J.
    Sancho, J.
    JOURNAL OF HYPERTENSION, 2007, 25 : S395 - S395
  • [8] Treatment with a combination of Olmesartan plus Amlodipine vs. Olmesartan plus Hydrochlorothiazide in hypertensive patients with metabolic syndrome increases insulin sensitivity and adiponectin and reduces inflammation markers
    Martinez-Martin, F. J.
    Macias-Batista, A.
    Rodriguez-Rosas, H.
    Soriano-Perera, P.
    Pedrianes-Martin, P.
    Comi-Diaz, C.
    Peiro-Martinez, I.
    JOURNAL OF HYPERTENSION, 2008, 26 : S331 - S331
  • [9] Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome
    Ng, Theodore W. K.
    Ooi, Esther M. M.
    Watts, Gerald F.
    Chan, Dick C.
    Weir, Jacquelyn M.
    Meikle, Peter J.
    Barrett, P. Hugh R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11): : E2335 - E2340
  • [10] The effects of telmisartan and amlodipine added to HCTZ on metabolic parameters and blood pressure in hypertensive patients with metabolic syndrome
    Girerd, X.
    Villeneuve, F.
    Marechal, E.
    Denert, E.
    Miljkovic, D.
    JOURNAL OF HYPERTENSION, 2008, 26 : S28 - S28
12345